Restructuring Clinical Trials to Find a Cure
Research!America and the Pancreatic Cancer Action Network held a meeting in New York this year to discuss ways to restructure clinical trials to find a cure for cancer.
Research!America and the Pancreatic Cancer Action Network held a meeting in New York this year to discuss ways to restructure clinical trials to find a cure for cancer.
As of April 01, 2014 All Pfizer Patient Assistance Programs have been consolidated into one program called Pfizer RxPathwaysTM.
Indian generic drug quality has been questioned recently by a number of U.S. doctors. The concern stems from FDA recalls and import bans.
A recent clinical trial found that 1 year of adjuvant imatinib was able to increase recurrence-free survival. Keep reading to learn more.
The LRG helped fund research by the University of Pittsburgh Cancer Institute (UPCI) to screen a library of FDA-approved anticancer drugs that previously wouldn’t have been considered as a treatment for GIST. UPCI scientists have been surprised at [...]
There are two new treatments that may have an impact on fighting GIST – immunotherapy and MRI-guided radiation. The LRG is continually looking into new treatments for GIST.
Today, February 4, 2014, marks a pivotal day of awareness across the planet. Cancer, a disease of many faces, has tortured and threatened the lives of millions of people all over the world. Its victims [...]
Over the past seven years, thanks to the dedication and support of the GIST community, the LRG Research Team has challenged the traditional cancer research norms and set new standards for how research can [...]
Dr. Brian Rubin of the LRG Research Clinic in Cleveland talks about the research we are able to do because of our amazing research team. He goes on to state that it is only a matter of time before we cure GIST. Our only obstacle is funding.
Is pregnancy for me?, is a common question among GIST patients. At present there isn't a lot of data on pregnancy and GIST. The prescription information on Gleevec clearly warns of risks if a [...]